CAS 1251765-07-7

Ticagrelor Amine ((1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol)

CAS : 1251765-07-7

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Formule : C₁₄H₂₂N₆O₄S

Couleur et forme : Off-White Powder

Masse moléculaire : 370.14232

Ref: 45-1A13030

1,2-Cyclopentanediol, 3-[7-amino-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-

CAS : 1251765-07-7

Formule : C₁₄H₂₂N₆O₄S

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 370.4273

Ref: IN-DA009C5Y

Ticagrelor EP Impurity A

CAS : 1251765-07-7

Formule : C₁₄H₂₂N₆O₄S

Couleur et forme : White To Off-White Solid

Masse moléculaire : 370.43

Ref: 4Z-T-8160

Ticagrelor metabolite M5

CAS : 1251765-07-7

Ticagrelor metabolite M5

Degré de pureté : ≥98%

Masse moléculaire : 370.43g/mol

Ref: 54-BUP02360

(1S,2S,3R,5S)-3-(7-Amino-5-(Propylthio)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-3-Yl)-5-(2-Hydroxyethoxy)Cyclopentane-1,2-Diol

CAS : 1251765-07-7

(1S,2S,3R,5S)-3-(7-Amino-5-(Propylthio)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-3-Yl)-5-(2-Hydroxyethoxy)Cyclopentane-1,2-Diol

Degré de pureté : 98%

Masse moléculaire : 370.43g/mol

Ref: 54-OR1023044

Ticagrelor metabolite M5

CAS : 1251765-07-7

Ticagrelor metabolite M5 (T437700) is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor.

Formule : C₁₄H₂₂N₆O₄S

Degré de pureté : 99.35%

Couleur et forme : Solid

Masse moléculaire : 370.43

Ref: TM-T21059

Ticagrelor EP Impurity A

CAS : 1251765-07-7

Formule : C₁₄H₂₂N₆O₄S

Masse moléculaire : 370.43

Ref: ST-EA-CP-T21001

AR-C133913XX

Produit contrôlé

CAS : 1251765-07-7

Stability Hygroscopic
Applications AR-C133913XX is an metabolte of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).
References Matetzky, S., et al.: Circulation, 109, 3171 (2004); Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007); Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)

Formule : C₁₄H₂₂N₆O₄S

Couleur et forme : Neat

Masse moléculaire : 370.43

Ref: TR-A766550

AR-C133913XX

CAS : 1251765-07-7

AR-C133913XX is a dietary supplement that belongs to the group of drugs known as adenosine receptor antagonists. It is used to treat cardiovascular diseases such as hypertension, coronary artery disease, and heart failure. AR-C133913XX reversibly blocks the A2A adenosine receptor in the caco-2 cells in order to reduce blood flow and increase vasoconstriction. This drug also has antiplatelet properties, which are due to its ability to inhibit platelet aggregation. AR-C133913XX is metabolized by glucuronidation and eliminated by renal excretion.

Formule : C₁₄H₁₅N₆O₄S

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 370.43 g/mol

Ref: 3D-BAC76507

(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS : 1251765-07-7

Degré de pureté : 99%

Masse moléculaire : 370.4299927

Ref: 10-F789339

AR-C133913XX-d7

Produit contrôlé

CAS : 1251765-07-7

Formule : C₁₄D₇H₁₅N₆O₄S

Couleur et forme : Neat

Masse moléculaire : 377.47

Ref: TR-A766552